Showing results (101-110 of 179) with videos related to
Sort By:
Pageof 18
Breast Cancer Research and Treatment|May 18, 1999
Prognostic factors in patients with isolated recurrences of breast cancer (stage IV-NED)O Juan, A Lluch, L de Paz, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2000
Circulating HER2 extracellular domain and resistance to chemotherapy in advanced breast cancerR Colomer, S Montero, A Lluch, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|April 16, 1993
Epidermal growth factor in human breast cancer, endometrial carcinoma and lung cancer. Its relationship to epidermal growth factor receptor, estradiol receptor and tumor TNMP Bolufer, A Lluch, R Molina, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1992
Aromatase activity and estradiol in human breast cancer: its relationship to estradiol and epidermal growth factor receptors and to tumor-node-metastasis stagingP Bolufer, E Ricart, A Lluch, et al.Bone Marrow Transplantation|August 5, 2000
Mobilization kinetics of peripheral blood progenitor cells after IAPVP-16 salvage chemotherapy plus G-CSF in lymphoproliferative disordersA Altés, R López, R Martino, et al.Vaccine|October 27, 2011
Pharmacoeconomic assessment of implementing a universal PCV-13 vaccination programme in the Valencian public health system (Spain)Javier Díez-Domingo, Manuel Ridao-López, M Victoria Gutiérrez-Gimeno, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|June 27, 1997
Prognostic significance of c-erbB-2/neu amplification and epidermal growth factor receptor (EGFR) in primary breast cancer and their relation to estradiol receptor (ER) statusD Torregrosa, P Bolufer, A Lluch, et al.Allergologia Et Immunopathologia|May 1, 1985
Mechanism of suppression of the depressed lymphocyte response in lung cancer patientsV Alberola, A González-Molina, A Trenor, et al.European Journal of Cancer (Oxford, England : 1990)|February 13, 2001
Heterogeneous lack of expression of the tumour suppressor PTEN protein in human neoplastic tissuesJ Torres, S Navarro, I Roglá, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2000
Gemcitabine in combination with doxorubicin in advanced breast cancer: final results of a phase II pharmacokinetic trialG Pérez-Manga, A Lluch, E Alba, et al.Pageof 18